Arxius de News - Page 13 of 25 - Institut de Neurociències

February 23, 2021 In News, Uncategorized By Laia Tremosa

New therapeutic target for Huntington’s treatment

Huntington’s disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive and psychiatric alterations. The origin of this disease has been associated with the anomalous functioning of the mutated protein: mHTT, but recent data showed the...

February 19, 2021 In News, Uncategorized By Laia Tremosa

ICREA Academia 2020 program awards five UB researchers

The grant program ICREA Academia 2020 has awarded five experts of the UB in a call that selected about thirty researchers from different knowledge fields framed within the Catalan university system. These grants, that reach their twelfth edition, are an initiative to contribute to hold the research talent...

These images show the nucleus of neurons in the CA1 region of the hippocampus with a marker for lamina B1. It shows the altered morphology of the nuclei of neurons in the R6/1 mouse, a model of Huntington's disease.

February 1, 2021 In News, Uncategorized By Laia Tremosa

Researchers describe molecular mechanism involved in Huntington’s neurodegeneration

These images show the nucleus of neurons in the CA1 region of the hippocampus with a marker for lamina B1. It shows the altered morphology of the nuclei of neurons in the R6/1 mouse, a model of Huntington's disease. Protein alteration in the family of lamins...

January 29, 2021 In News, Uncategorized By Laia Tremosa

Stem cell AI – ‘brain on a chip’ project aims to revolutionise computing power

NEU-ChiP project, headed at the University of Barcelona by Daniel Tornero (researcher at the Institute of Neurosciences and IDIBAPS) and Jordi Soriano (researcher at UBICS), aims to develop microchips made of neuronal circuits using human induced pluripotent stem cells. The neurons will connect to each...

January 25, 2021 In News, Success Story, Uncategorized By Laia Tremosa

AIGecko Technologies is born, artificial intelligence at the service of image recognition

Deep learning is a field of artificial intelligence that in recent years has revolutionized the market and our daily lives in aspects such as automatic driving, artificial vision or virtual assistants, among many other applications. "Deep learning technology allows a computer to learn to automatically...

December 23, 2020 In News By Laia Tremosa

NEUROPA: new innovative European project to treat neurodegenerative diseases with laser light

The research group for Monitoring and Modulation of Brain Circuits in Brain Diseases of the Institute of Neurosciences (UBNeuro) led by Dr. Mercè Masana participates in the NEUROPA project. The project is led by a pioneering international consortium in the field of phyto-optogenetics, with experts...

December 23, 2020 In News By Laia Tremosa

Researchers discover a new biomarker candidate to diagnose ALS cases in early stages

Amyotrophic Lateral Sclerosis (ALS) is a degenerative disease which affects the neurons that control the muscular tissue. As the disease progresses, these motoneurons stop working and end up dying, which causes a progressive muscular paralysis with a life-threatening prognosis. Unlike the familial ALS (fALS), which...

December 17, 2020 In News By Laia Tremosa

How does immersive reality affect implicit racial bias?

Implicit racial bias refers to the automatic non-conscious behaviours, even if one’s explicit attitude is not biased at all. Several studies have shown these prejudices are reduced in white people after being in the body of a black person in virtual reality. Now, a study...

December 9, 2020 In News By Laia Tremosa

Researchers identify an action mechanism for a drug against Alzheimer‘ disease

A study conducted on mice published in the journalGeroscience has identified the action mechanism of a promising compound against Alzheimer’s disease, developed by the team of Medical Chemistry and Pharmacology at the University of Barcelona. The new drug belongs to a family of molecules that, when bound to...

December 3, 2020 In News, Uncategorized By Laia Tremosa

L’Institut de Neurociències UB reb més d’1,5 milions d’euros per la recerca de malalties minoritàries gràcies a La Marató de TV3

L’Institut de Neurociències de la Universitat de Barcelona ajudarà en l‘avanç de la recerca de malalties minoritàries tals com la Neurofibromatosi i el Huntington gràcies al finançament concedit per La Marató de TV3. Concretament, els nostres investigadors han aconseguit 5 projectes per un total de més de 1,5...